4.8 Article

Inhibition of Spleen Tyrosine Kinase Activation Ameliorates Inflammation, Cell Death, and Steatosis in Alcoholic Liver Disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Gastroenterology & Hepatology

Gut-Liver Axis in Alcoholic Liver Disease

Gyongyi Szabo

GASTROENTEROLOGY (2015)

Article Pharmacology & Pharmacy

Modulation of tamoxifen-induced hepatotoxicity by tamoxifen-phospholipid complex

Sunil K. Jena et al.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2015)

Review Gastroenterology & Hepatology

Inflammasome activation and function in liver disease

Gyongyi Szabo et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)

Review Gastroenterology & Hepatology

Alcohol liver disease: A review of current therapeutic approaches to achieve long-term abstinence

Maria Luisa Gutierrez Garcia et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2015)

Article Gastroenterology & Hepatology

Animals Models of Gastrointestinal and Liver Diseases. Animal models of alcohol-induced liver disease: pathophysiology, translational relevance, and challenges

Stephanie Mathews et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)

Editorial Material Immunology

Tyrosine kinases: the molecular switch for inflammasome activation

Federica Laudisi et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2014)

Review Immunology

Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases

H. Patterson et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)

Review Gastroenterology & Hepatology

Host-Microbiome Interactions in Alcoholic Liver Disease

Peng Chen et al.

GUT AND LIVER (2014)

Review Gastroenterology & Hepatology

Gut microbiota and liver disease

Amit Goel et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)

Article Gastroenterology & Hepatology

Pharmacotherapy of acute alcoholic hepatitis in clinical practice

Ludovico Abenavoli et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Review Pharmacology & Pharmacy

New spleen tyrosine kinase inhibitors: patent applications published during 2011-2013

Atli Thorarensen et al.

PHARMACEUTICAL PATENT ANALYST (2014)

Article Gastroenterology & Hepatology

Human Ezrin-Moesin-Radixin Proteins Modulate Hepatitis C Virus Infection

Terence N. Bukong et al.

HEPATOLOGY (2013)

Article Gastroenterology & Hepatology

Therapeutic potential of interleukin 1 inhibitors in the treatment of alcoholic liver disease

Stephanie Mathews et al.

HEPATOLOGY (2013)

Article Biochemical Research Methods

Mouse model of chronic and binge ethanol feeding (the NIAAA model)

Adeline Bertola et al.

NATURE PROTOCOLS (2013)

Article Multidisciplinary Sciences

STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease

Jan Petrasek et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Substance Abuse

Rodent models of alcoholic liver disease: Of mice and men

Elizabeth Brandon-Warner et al.

ALCOHOL (2012)

Review Pharmacology & Pharmacy

The SYK side of TLR4: signalling mechanisms in response to LPS and minimally oxidized LDL

Yury I. Miller et al.

BRITISH JOURNAL OF PHARMACOLOGY (2012)

Article Gastroenterology & Hepatology

Prevalence and Natural History of Alcoholic Liver Disease

Jonathan M. Schwartz et al.

CLINICS IN LIVER DISEASE (2012)

Article Medicine, Research & Experimental

IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice

Jan Petrasek et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Article Pharmacology & Pharmacy

The 2010 Patent Landscape for Spleen Tyrosine Kinase Inhibitors

Alessandro F. Moretto et al.

RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY (2012)

Article Substance Abuse

Molecular Mechanisms of Alcoholic Liver Disease: Innate Immunity and Cytokines

Andrew M. Miller et al.

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2011)

Review Gastroenterology & Hepatology

Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets

Bin Gao et al.

GASTROENTEROLOGY (2011)

Review Gastroenterology & Hepatology

Alcoholic Liver Disease

Robert S. O'Shea et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)

Article Gastroenterology & Hepatology

Spleen tyrosine kinase inhibition prevents tissue damage after ischemia-reperfusion

Omer Nuri Pamuk et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)

Article Gastroenterology & Hepatology

Alcoholic hepatitis 2010: A clinician's guide to diagnosis and therapy

Maziyar Amini et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2010)

Review Gastroenterology & Hepatology

Toll-Like Receptors in the Pathogenesis of Alcoholic Liver Disease

Jan Petrasek et al.

GASTROENTEROLOGY RESEARCH AND PRACTICE (2010)

Review Immunology

The SYK tyrosine kinase: a crucial player in diverse biological functions

Attila Mocsai et al.

NATURE REVIEWS IMMUNOLOGY (2010)

Article Cardiac & Cardiovascular Systems

Lipoprotein Accumulation in Macrophages via Toll-Like Receptor-4-Dependent Fluid Phase Uptake

Soo-Ho Choi et al.

CIRCULATION RESEARCH (2009)

Review Immunology

Autoinhibition and adapter function of Syk

Yogesh Kulathu et al.

IMMUNOLOGICAL REVIEWS (2009)

Review Gastroenterology & Hepatology

Signalling pathways in alcohol-induced liver inflammation

Pranoti Mandrekar et al.

JOURNAL OF HEPATOLOGY (2009)

Review Medicine, General & Internal

MEDICAL PROGRESS Alcoholic Hepatitis

Michael R. Lucey et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Pharmacology & Pharmacy

R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation

Sylvia Braselmann et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)

Review Gastroenterology & Hepatology

Apoptosis: a mechanism of acute and chronic liver injury

ME Guicciardi et al.

Article Immunology

Syk is required for integrin signaling in neutrophils

A Mócsai et al.

IMMUNITY (2002)